Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000255265 | SCV000321892 | pathogenic | not provided | 2023-10-03 | criteria provided, single submitter | clinical testing | Frameshift variant predicted to result in protein truncation or nonsense mediated decay in a gene for which loss-of-function is a known mechanism of disease; This variant is associated with the following publications: (PMID: 16714263, 31589614, 31725702, 33188265, 26355662, 32783370) |
Genomic Medicine Center of Excellence, |
RCV004760469 | SCV005374044 | pathogenic | Retinitis pigmentosa 38 | 2024-09-22 | criteria provided, single submitter | clinical testing | |
Al Jalila Children’s Genomics Center, |
RCV004760469 | SCV005420587 | pathogenic | Retinitis pigmentosa 38 | 2024-10-04 | criteria provided, single submitter | research | PVS1,PM3,PM2 |
Labcorp Genetics |
RCV000255265 | SCV005834827 | pathogenic | not provided | 2024-07-23 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Cys738Trpfs*32) in the MERTK gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in MERTK are known to be pathogenic (PMID: 24265693, 29659094). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with retinal dystrophy (PMID: 16714263). ClinVar contains an entry for this variant (Variation ID: 265244). For these reasons, this variant has been classified as Pathogenic. |
Faculty of Health Sciences, |
RCV001257795 | SCV001434672 | pathogenic | Autosomal recessive retinitis pigmentosa | 2019-11-08 | no assertion criteria provided | literature only |